Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2006) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Current Pharmacogenomics | journal | 0.183 Q3 | 12 | 33 | 56 | 2875 | 34 | 56 | 0.61 | 87.12 |  |
| 52 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 |  |
| 53 | Journal of NeuroImmune Pharmacology | journal | 91 | 40 | 0 | 3423 | 0 | 0 | 0.00 | 85.58 |  | |
| 54 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
| 55 | Mini-Reviews in Medicinal Chemistry | journal | 0.975 Q1 | 107 | 141 | 272 | 11742 | 944 | 257 | 3.60 | 83.28 |  |
| 56 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 4 | 166 | 0 | 4 | 0.00 | 83.00 | | |
| 57 | Expert Opinion on Drug Delivery | journal | 0.588 Q1 | 133 | 65 | 97 | 5359 | 207 | 93 | 2.13 | 82.45 | |
| 58 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
| 59 | Drug Metabolism Reviews | journal | 1.571 Q1 | 108 | 46 | 88 | 3653 | 517 | 87 | 5.60 | 79.41 | |
| 60 | Expert Review of Vaccines | journal | 0.810 Q2 | 105 | 76 | 265 | 6009 | 679 | 243 | 2.24 | 79.07 | |
| 61 | Journal of International Peacekeeping | journal | 0.100 Q4 | 14 | 10 | 39 | 790 | 2 | 37 | 0.05 | 79.00 | |
| 62 | Frontiers in Drug Design and Discovery | book series | 9 | 18 | 0 | 1416 | 0 | 0 | 0.00 | 78.67 | | |
| 63 | Advances in Phytomedicine | book series | 15 | 43 | 0 | 3377 | 0 | 0 | 0.00 | 78.53 | | |
| 64 | Advances in Pharmacology | journal | 0.151 Q4 | 86 | 42 | 54 | 3296 | 24 | 50 | 0.44 | 78.48 | |
| 65 | Current Nanoscience | journal | 52 | 35 | 0 | 2729 | 0 | 0 | 0.00 | 77.97 | | |
| 66 | Current Pharmaceutical Biotechnology | journal | 1.000 Q1 | 97 | 60 | 145 | 4656 | 459 | 129 | 3.08 | 77.60 | |
| 67 | Cardiovascular Drug Reviews | journal | 0.682 Q2 | 54 | 21 | 73 | 1607 | 159 | 73 | 2.10 | 76.52 | |
| 68 | Core Evidence (discontinued) | journal | 0.102 Q4 | 29 | 8 | 12 | 596 | 0 | 11 | 0.00 | 74.50 |  |
| 69 | Marine Drugs | journal | 0.589 Q2 | 159 | 18 | 39 | 1338 | 66 | 36 | 1.84 | 74.33 |  |
| 70 | Addiction Biology | journal | 0.754 Q2 | 93 | 33 | 132 | 2367 | 259 | 120 | 2.05 | 71.73 | |
| 71 | Current Topics in Pharmacology | journal | 8 | 18 | 0 | 1285 | 0 | 0 | 0.00 | 71.39 |  | |
| 72 | Reviews on Recent Clinical Trials | journal | 35 | 31 | 0 | 2212 | 0 | 0 | 0.00 | 71.35 | | |
| 73 | Current Drug Safety | journal | 41 | 33 | 0 | 2335 | 0 | 0 | 0.00 | 70.76 | | |
| 74 | Expert Opinion on Pharmacotherapy | journal | 0.565 Q2 | 93 | 226 | 676 | 15502 | 1536 | 663 | 2.27 | 68.59 | |
| 75 | Current Drug Delivery | journal | 0.498 Q1 | 72 | 46 | 83 | 3115 | 184 | 82 | 2.22 | 67.72 | |
| 76 | Current Drug Discovery Technologies | journal | 0.418 Q3 | 49 | 22 | 46 | 1460 | 101 | 45 | 2.20 | 66.36 | |
| 77 | Neurotoxicity Research | journal | 0.990 Q1 | 84 | 55 | 170 | 3615 | 542 | 167 | 3.27 | 65.73 | |
| 78 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
| 79 | Birth Defects Research Part B - Developmental and Reproductive Toxicology | journal | 0.486 Q3 | 58 | 32 | 108 | 2041 | 230 | 103 | 1.94 | 63.78 | |
| 80 | Therapeutics and Clinical Risk Management | journal | 70 | 47 | 0 | 2919 | 0 | 0 | 0.00 | 62.11 | | |
| 81 | Expert Opinion on Drug Discovery | journal | 84 | 65 | 0 | 4028 | 0 | 0 | 0.00 | 61.97 | | |
| 82 | AAPS Journal | journal | 0.356 Q2 | 132 | 90 | 188 | 5555 | 343 | 182 | 1.98 | 61.72 | |
| 83 | Expert Opinion on Therapeutic Patents | journal | 0.456 Q3 | 88 | 117 | 362 | 7106 | 494 | 350 | 1.53 | 60.74 | |
| 84 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.336 Q3 | 56 | 70 | 237 | 4210 | 273 | 236 | 1.19 | 60.14 |  |
| 85 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | |
| 86 | Toxin Reviews | journal | 0.242 Q3 | 54 | 29 | 90 | 1716 | 84 | 83 | 0.96 | 59.17 | |
| 87 | Chinese Medicine | journal | 56 | 4 | 0 | 235 | 0 | 0 | 0.00 | 58.75 | | |
| 88 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | |
| 89 | Drug Development Research | journal | 0.306 Q3 | 67 | 98 | 304 | 5673 | 297 | 298 | 0.96 | 57.89 | |
| 90 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
| 91 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
| 92 | Current Opinion in Molecular Therapeutics | journal | 0.908 Q2 | 67 | 69 | 270 | 3935 | 701 | 241 | 2.55 | 57.03 | |
| 93 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.435 Q3 | 50 | 44 | 79 | 2503 | 119 | 76 | 1.37 | 56.89 | |
| 94 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
| 95 | Molecular Diagnosis and Therapy | journal | 68 | 43 | 186 | 2421 | 548 | 184 | 2.88 | 56.30 | | |
| 96 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.126 Q4 | 40 | 7 | 64 | 387 | 15 | 64 | 0.03 | 55.29 | |
| 97 | Neurotoxicology and Teratology | journal | 0.815 Q2 | 111 | 70 | 217 | 3823 | 602 | 209 | 2.52 | 54.61 | |
| 98 | International Journal of Toxicology | journal | 0.339 Q3 | 71 | 58 | 201 | 3132 | 224 | 179 | 0.86 | 54.00 | |
| 99 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | |
| 100 | Psychopharmacology | journal | 1.892 Q1 | 214 | 366 | 1156 | 19456 | 5043 | 1107 | 4.18 | 53.16 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data